Trial · NCT00666965
Results by group160
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 160
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change of International Restless Legs Syndrome Study Group Rating Scale (IRLS) Score From the Baseline to the End of Titration/Maintenance Period | Placebo | -9.8 | Standard Deviation 7.2 | scores on a scale | |
| Change of International Restless Legs Syndrome Study Group Rating Scale (IRLS) Score From the Baseline to the End of Titration/Maintenance Period | 2.25 mg/Day | -10.7 | Standard Deviation 6.3 | scores on a scale | |
| Change of International Restless Legs Syndrome Study Group Rating Scale (IRLS) Score From the Baseline to the End of Titration/Maintenance Period | 4.5 mg/Day | -14.4 | Standard Deviation 7.2 | scores on a scale | |
| Change of International Restless Legs Syndrome Study Group Rating Scale (IRLS) Score From the Baseline to the End of Titration/Maintenance Period | 6.75 mg/Day | -14.1 | Standard Deviation 8.8 | scores on a scale | |
| Clinical Global Impression (CGI) Severity | Placebo | Decreased | 73.7 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 2.25 mg/Day | Decreased | 83.6 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 4.5 mg/Day | Decreased | 92.9 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 6.75 mg/Day | Decreased | 86.3 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | Placebo | Increased | 1.8 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 2.25 mg/Day | Increased | 1.8 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 4.5 mg/Day | Increased | 0.0 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 6.75 mg/Day | Increased | 3.9 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | Placebo | Decreased to 1 or 2 | 12.3 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 2.25 mg/Day | Decreased to 1 or 2 | 18.2 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 4.5 mg/Day | Decreased to 1 or 2 | 41.1 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 6.75 mg/Day | Decreased to 1 or 2 | 39.2 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | Placebo | Subjects with CGI score 5 | 8.8 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 2.25 mg/Day | Subjects with CGI score 5 | 12.7 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 4.5 mg/Day | Subjects with CGI score 5 | 3.6 | Percentage of Participants | |
| Clinical Global Impression (CGI) Severity | 6.75 mg/Day | Subjects with CGI score 5 | 7.8 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00666965/results